Bath & Body Works, Inc.

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Net Income $1.2b
$983.0m -15.11%
$644.0m -34.49%
($366.0m) -156.83%
$844.0m +330.60%
$1.3b +57.94%
$800.0m -39.98%
$878.0m +9.75%
$798.0m -9.11%
$649.0m -18.67%
$727.0m +12.02%
Depreciation of Long-lived Assets $518.0m $571.0m $590.0m $588.0m $521.0m $363.0m $221.0m $269.0m $282.0m $254.0m $251.0m
Deferred Income Taxes $110.0m ($108.0m) ($52.0m) ($29.0m) $33.0m $45.0m $17.0m ($128.0m) ($112.0m) $63.0m $1.0m
Share-based Compensation Expense $96.0m $102.0m $97.0m $87.0m $50.0m $46.0m $38.0m $43.0m $40.0m $31.0m $29.0m
Tax Payments related to Share-based Awards ($58.0m) ($32.0m) ($13.0m) ($13.0m) ($12.0m) ($59.0m) ($32.0m) ($11.0m) ($16.0m) ($8.0m)
Impairment of Equity Method Investment $0 $0 $8.0m $0 $0
Accounts Receivable ($44.0m) ($13.0m) ($63.0m) $31.0m $38.0m ($64.0m) $11.0m $2.0m $18.0m $25.0m $4.0m
Inventories $30.0m ($137.0m) ($40.0m) ($40.0m) $3.0m ($177.0m) $0 ($2.0m) ($26.0m) $37.0m $88.0m
Accounts Payable, Accrued Expenses and Other ($27.0m) $50.0m $29.0m ($93.0m) $166.0m ($86.0m) $44.0m ($109.0m) ($50.0m) $111.0m $131.0m
Other Assets and Liabilities $100.0m $20.0m $130.0m ($15.0m) $213.0m ($91.0m) ($26.0m) ($7.0m) ($12.0m) ($3.0m)
Net Cash Provided by Operating Activities $1.9b
$1.4b -25.61%
$1.4b -2.06%
$1.2b -10.24%
$2.0b +64.97%
$1.5b -26.83%
$1.1b -23.32%
$954.0m -16.61%
$886.0m -7.13%
$1.1b +24.38%
$1.2b +5.08%
Capital Expenditures ($990.0m) ($707.0m) ($629.0m) ($458.0m) ($228.0m) ($270.0m) ($328.0m) ($298.0m) ($226.0m) ($237.0m) ($249.0m)
Gain on Sales of Easton Investments $0 $0 ($39.0m) $0
Other Investing Activities $19.0m ($10.0m) $4.0m ($22.0m) $9.0m $11.0m $0 $12.0m $24.0m $1.0m
Net Cash Used for Investing Activities ($833.0m) ($698.0m) ($609.0m) ($480.0m) ($219.0m) ($259.0m) ($328.0m) ($286.0m) ($162.0m) ($227.0m)
Loss on extinguishment of debt ($36.0m) ($45.0m) $0 ($40.0m) ($53.0m) $195.0m $0 ($34.0m) $10.0m $0
Payments for Long-term Debt ($742.0m) ($540.0m) ($52.0m) ($799.0m) ($1.3b) ($1.7b) $0 ($447.0m) ($522.0m) $0
Repurchases of Common Stock ($435.0m) ($446.0m) ($198.0m) $0 $0 ($2.0b) ($1.3b) ($148.0m) ($401.0m) ($401.0m)
Dividends Paid ($1.3b) ($686.0m) ($666.0m) ($332.0m) ($83.0m) ($120.0m) ($186.0m) ($182.0m) ($177.0m) ($167.0m) ($164.0m)
Other Financing Activities ($3.0m) ($3.0m) ($7.0m) ($14.0m) $2.0m $0 ($4.0m) ($13.0m) $3.0m ($9.0m)
Net Cash Used for Financing Activities ($1.7b)
($1.1b) +32.31%
($872.0m) +22.63%
($666.0m) +23.62%
$610.0m +191.59%
($3.2b) -622.62%
($1.6b) +51.00%
($815.0m) +47.82%
($1.1b) -38.90%
($599.0m) +47.08%
Net Increase (Decrease) in Cash and Cash Equivalents ($614.0m) ($419.0m) ($102.0m) $86.0m $2.4b ($2.0b) ($747.0m) ($148.0m) ($410.0m) $279.0m
Cash and Cash Equivalents, Beginning of Year $2.5b $1.9b $1.5b $1.4b $3.9b $2.0b $1.2b $1.1b $674.0m $953.0m
Effects of Exchange Rate Changes on Cash and Cash Equivalents $4.0m $1.0m ($1.0m) ($1.0m) ($2.0m) $3.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Gain on Sale of Non-core Asset $0 $0 ($8.0m)
Income Taxes Payable $117.0m ($40.0m) ($113.0m) $18.0m ($43.0m) ($72.0m) $39.0m $34.0m ($23.0m) ($57.0m)
Proceeds from Sale of Non-core Asset $0 $0 $9.0m
Payments of Finance Lease Obligations ($4.0m) ($8.0m) ($53.0m) ($12.0m) ($9.0m) ($15.0m) ($17.0m) ($14.0m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.